442 related articles for article (PubMed ID: 22971207)
1. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
Jasińska-Stroschein M; Owczarek J; Wesołowska A; Orszulak-Michalak D
Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
Jiang L; Zhou T; Liu H
Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
[TBL] [Abstract][Full Text] [Related]
6. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1-dependent pathway.
Zhang WH; Zhang YJ; Liu CP; Yu BX; Lu WX
Exp Lung Res; 2011 Oct; 37(8):492-9. PubMed ID: 21867382
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
9. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Satoh M; Satoh A
J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
[TBL] [Abstract][Full Text] [Related]
10. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
Zeng Z; Li Y; Jiang Z; Wang C; Li B; Jiang W
Cardiovasc Ther; 2010; 28(1):23-9. PubMed ID: 20074256
[TBL] [Abstract][Full Text] [Related]
11. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
13. [Simvastatin prevents the development of pulmonary hypertension in the rats through reduction of inflammation].
Zhang WH; Lu WX; Zhang YJ; Ji YQ; Liu CP; Li G
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):855-9. PubMed ID: 19595129
[TBL] [Abstract][Full Text] [Related]
14. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
15. Effects of masitinib compared with tadalafil for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2019; 122-123():106599. PubMed ID: 31629919
[TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
Xie L; Lin P; Xie H; Xu C
Clin Exp Hypertens; 2010; 32(8):547-54. PubMed ID: 21091363
[TBL] [Abstract][Full Text] [Related]
17. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
Zhao L; Zhou TF; Liu HM; Li M; Dou H; Tang ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
[TBL] [Abstract][Full Text] [Related]
18. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.
Liu B; Wang XQ; Yu L; Zhou TF; Wang XM; Liu HM
Exp Lung Res; 2009 Jun; 35(5):411-26. PubMed ID: 19842842
[TBL] [Abstract][Full Text] [Related]
20. [Protective effects of beraprost plus simvastatin on monocrotaline-induced pulmonary arterial hypertension in rats].
Wang SH; Liu S; Yang JH; Wang ZZ; Li J; Hou WW
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1691-5. PubMed ID: 24124673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]